J Illnait

1.4k total citations
40 papers, 1.1k citations indexed

About

J Illnait is a scholar working on Surgery, Nutrition and Dietetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, J Illnait has authored 40 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Surgery, 4 papers in Nutrition and Dietetics and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in J Illnait's work include Natural Products and Biological Research (35 papers), Lipoproteins and Cardiovascular Health (19 papers) and Fatty Acid Research and Health (4 papers). J Illnait is often cited by papers focused on Natural Products and Biological Research (35 papers), Lipoproteins and Cardiovascular Health (19 papers) and Fatty Acid Research and Health (4 papers). J Illnait collaborates with scholars based in Cuba, Lebanon and Greece. J Illnait's co-authors include G Castaño, Rosa Más, Lara P. Fernández, Julio César Fernández, R Más, Enric Álvarez, José María Pérez Fernández, Celia Alemán, M. Rodriguez and M. Carmen González and has published in prestigious journals such as The Journals of Gerontology Series A, Clinical Pharmacology & Therapeutics and Atherosclerosis.

In The Last Decade

J Illnait

39 papers receiving 968 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Illnait Cuba 21 1.0k 221 108 86 83 40 1.1k
José Illnait Cuba 18 850 0.8× 191 0.9× 113 1.0× 77 0.9× 61 0.7× 44 980
Lilia Fernández Cuba 20 792 0.8× 184 0.8× 95 0.9× 75 0.9× 50 0.6× 36 931
M.L. Arruzazabala Cuba 20 694 0.7× 242 1.1× 82 0.8× 96 1.1× 69 0.8× 32 977
S. Valdés Cuba 16 588 0.6× 181 0.8× 108 1.0× 64 0.7× 40 0.5× 26 711
Gladys Castaño Cuba 15 593 0.6× 151 0.7× 50 0.5× 63 0.7× 49 0.6× 28 642
V. Molina Cuba 17 407 0.4× 133 0.6× 55 0.5× 53 0.6× 39 0.5× 25 629
Vivián Molina Cuba 17 412 0.4× 115 0.5× 133 1.2× 23 0.3× 50 0.6× 47 693
Giuseppa Castellino Italy 11 186 0.2× 52 0.2× 39 0.4× 67 0.8× 51 0.6× 15 695
Jason D’Souza United States 9 82 0.1× 134 0.6× 229 2.1× 72 0.8× 40 0.5× 23 591
Yoshinobu Ijiri Japan 14 108 0.1× 76 0.3× 37 0.3× 193 2.2× 94 1.1× 29 726

Countries citing papers authored by J Illnait

Since Specialization
Citations

This map shows the geographic impact of J Illnait's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Illnait with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Illnait more than expected).

Fields of papers citing papers by J Illnait

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Illnait. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Illnait. The network helps show where J Illnait may publish in the future.

Co-authorship network of co-authors of J Illnait

This figure shows the co-authorship network connecting the top 25 collaborators of J Illnait. A scholar is included among the top collaborators of J Illnait based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Illnait. J Illnait is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sanz‐Sánchez, Jorge, et al.. (2017). [Long-term effect of policosanol on the functional recovery of non-cardioembolic ischemic stroke patients: a one year study].. PubMed. 64(4). 153–161. 3 indexed citations
2.
Sánchez, Javier, Rosa Más, Lara P. Fernández, et al.. (2006). Effects of Policosanol on Patients with Ischemic Stroke: A Pilot Open Study. Journal of Medicinal Food. 9(3). 378–385. 11 indexed citations
3.
Castaño, G, Rosa Más, Lara P. Fernández, et al.. (2005). A comparison of the effects of D-003 and policosanol (5 and 10 mg/day) in patients with type II hypercholesterolemia: a randomized, double-blinded study.. PubMed. 31 Suppl. 31–44. 13 indexed citations
4.
Más, R, G Castaño, Lara P. Fernández, et al.. (2005). The effect of D-003 (10 mg/day) on biochemical parameters of bone remodelling in postmenopausal women: a randomized, double-blind study.. PubMed. 25(4). 175–86. 6 indexed citations
5.
Arruzazabala, M.L., Rosa Más, V. Molina, et al.. (2004). Effects of d-003, a new substance purified from sugar cane wax, on platelet aggregation and plasma levels of arachidonic acid metabolites in healthy volunteers.. PubMed. 24(2-3). 55–63. 5 indexed citations
6.
Más, Rosa, G Castaño, Julio César Fernández, et al.. (2003). Long-term effects of policosanol on older hypertensive patients with type II hypercholesterolemia. Heart Lung and Circulation. 12(2). A40–A40.
8.
Illnait, J, et al.. (2002). Effects of Policosanol on Older Patients with Hypertension and Type II Hypercholesterolaemia. Drugs in R&D. 3(3). 159–172. 30 indexed citations
9.
Illnait, J, et al.. (2002). Assessment of the Effects of D-003, a New Antiplatelet and Lipid-Lowering Compound, in Healthy Volunteers. Drugs in R&D. 3(5). 337–348. 24 indexed citations
10.
Menéndez, Roberto, et al.. (2001). Effects of D-002 on Lipid Peroxidation in Older Subjects. Journal of Medicinal Food. 4(2). 71–77. 22 indexed citations
11.
Castaño, G, et al.. (2001). Effects of policosanol 20 versus 40 mg/day in the treatment of patients with type II hypercholesterolemia: a 6-month double-blind study.. PubMed. 21(1). 43–57. 39 indexed citations
12.
Castaño, G, et al.. (2001). Effects of Policosanol in Older Patients With Type II Hypercholesterolemia and High Coronary Risk. The Journals of Gerontology Series A. 56(3). M186–M193. 58 indexed citations
13.
Castaño, G, Rosa Más, Lara P. Fernández, et al.. (2000). Effects of policosanol on postmenopausal women with type II hypercholesterolemia. Gynecological Endocrinology. 14(3). 187–195. 51 indexed citations
14.
Castaño, G, Rosa Más, Julio César Fernández, et al.. (2000). Effect of policosanol in older patients with type II hypercholesterolemia and high coronary risk. Atherosclerosis. 151(1). 317–317. 3 indexed citations
15.
Más, R, et al.. (1999). Effects of policosanol in patients with type II hypercholesterolemia and additional coronary risk factors. Clinical Pharmacology & Therapeutics. 65(4). 439–447. 105 indexed citations
16.
Más, Rosa, G Castaño, Julio César Fernández, et al.. (1999). Effects of policosanol on postmenopausal women with type II hypercholesterolemia. Atherosclerosis. 144. 184–184. 2 indexed citations
17.
Castaño, G, et al.. (1999). Effects of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients.. PubMed. 19(4). 105–16. 62 indexed citations
18.
Más, Rosa, et al.. (1993). Effect of successive dose increases of policosanol on the lipid profile and tolerability of treatment. Current Therapeutic Research. 54(3). 304–312. 40 indexed citations
19.
Hernández, Fuensanta, J Illnait, R Más, et al.. (1992). Effect of policosanol on serum lipids and lipoproteins in healthy volunteers. Current Therapeutic Research. 51(4). 568–575. 84 indexed citations
20.
Illnait, J, et al.. (1987). Changes in the aorta of guinea pigs exposed to kerosene.. PubMed. 35(1-2). 59–69. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026